Daiichi Sankyo has expanded its presence in Canada with the official opening of its permanent headquarters in Toronto, including additional operational and R&D investments to advance its efforts in oncology. “Establishing a permanent headquarters in Toronto represents a significant milestone in our global expansion and reflects the strong commitment of Daiichi Sankyo to patients and partners in Canada,” said Masahiro Kato, Managing Director, Europe and Canada, Daiichi Sankyo. &#8220...